高级检索
当前位置: 首页 > 详情页

Multifaceted role of TRIM28 in health and disease

文献详情

资源类型:
Pubmed体系:
机构: [1]Key Laboratory of Epigenetics and Oncology the Research Center for Preclinical Medicine Southwest Medical University Luzhou Sichuan China. [2]Department of Cellular and Molecular Biology and Microbiology Faculty of Biological Science and Technology University of Isfahan Isfahan Iran. [3]Department of Microbiology and Genetic Kherad Institute of Higher Education Busheher Iran. [4]Farhikhtegan Medical Convergence Sciences Research Center Farhikhtegan Hospital Tehran Medical Sciences Islamic Azad University Tehran Iran. [5]Department of Genetics Faculty of Advanced Science and Technology Tehran Medical Sciences Islamic Azad University Tehran Iran.
出处:

关键词: cancer pathogenesis cancer therapy DNA damage response transcriptional regulation TRIM family TRIM28

摘要:
The TRIM (tripartite motif) family, with TRIM28 as a key member, plays a vital role in regulating health and disease. TRIM28 contains various functional domains essential for transcriptional regulation, primarily through its interaction with KRAB-ZNF proteins, which influence chromatin remodeling and gene expression. Despite extensive research, the precise mechanisms by which TRIM28 impacts health and disease remain elusive. This review delves into TRIM28's multifaceted roles in maintaining health, contributing to a variety of diseases, and influencing cancer progression. In cancers, TRIM28 exhibits a dual nature, functioning as both a tumor promoter and suppressor depending on the cellular context and cancer type. The review also explores its critical involvement in processes such as DNA repair, cell cycle regulation, epithelial-to-mesenchymal transition, and the maintenance of stem cell properties. By uncovering TRIM28's complex roles across different cancers and other diseases, this review underscores its potential as a therapeutic target. The significance of TRIM28 as a versatile regulator opens the door to innovative therapeutic strategies, particularly in cancer treatment and the management of other diseases. Ongoing research into TRIM28 may yield key insights into disease progression and novel treatment options.© 2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验
第一作者:
第一作者机构: [1]Key Laboratory of Epigenetics and Oncology the Research Center for Preclinical Medicine Southwest Medical University Luzhou Sichuan China.
共同第一作者:
通讯作者:
通讯机构: [4]Farhikhtegan Medical Convergence Sciences Research Center Farhikhtegan Hospital Tehran Medical Sciences Islamic Azad University Tehran Iran. [5]Department of Genetics Faculty of Advanced Science and Technology Tehran Medical Sciences Islamic Azad University Tehran Iran.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:53699 今日访问量:0 总访问量:4607 更新日期:2025-02-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号